Stocks To Buy Now

Blog


Bowser Small Cap Stocks Grew 2.6% for Week Ended September 22, Outperforming Major Indices

  • Leading the way was InfuSystem Holdings (NYSE MKT: INFU), which grew 23%
  • Russell 2000 Index increased 1.3%, faster than other major indices
  • Second week in a row Bowser Stocks surged higher

Bowser small cap stocks grew 2.6% for the week ended September 22, outperforming major indices, according to The Bowser Report Weekly. InfuSystem Holdings (NYSE MKT: INFU) led the way, growing 23% for the week. Ironically, INFU was the single biggest loser the prior week, with The Bowser Report Weekly attributing that selloff to an increase in volatility. The company provides infusion pumps and related services to medical facilities.

It was the second week in a row that Bowser Stocks showed growth. The Russell 2000 index grew at a 1.3% rate, outperforming the major indices. The Dow Jones Industrial Average (DJIA) grew just 0.4%, and the S&P 500 was up only 0.1%. The report said that smaller stocks are exhibiting relative strength for the one-month period. It expects, though, a loss of growth momentum at a historical supply zone.

The second biggest gainer was Nova Lifestyle (NASDAQ: NVFY), which showed 18% growth. That stock is now up 54% from its 52-week low. The company earlier announced in a press release that it was receiving an award and also expecting growth in the fourth quarter, driven by new product launches and an increase in consumer demand. It is a California-based consumer furniture manufacturer.

For the week, 32 Bowser stocks showed growth and only 11 were in the red. The report added that gold experienced a sharp pullback for the week due to the strength of the U.S. dollar. The report attributed that to a Federal Reserve decision to leave interest rates unchanged.

For more information, refer to The Bowser Report Weekly

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

May 13, 2025

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies […]

Rotate your device 90° to view site.